The authors declare that they have no conflicts of interest.
Article first published online: 7 JUN 2012
Copyright © 2012 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part A
Volume 158A, Issue 7, pages 1633–1640, July 2012
How to Cite
Thierry, G., Bénéteau, C., Pichon, O., Flori, E., Isidor, B., Popelard, F., Delrue, M.-A., Duboscq-Bidot, L., Thuresson, A.-C., van Bon, B. W.M., Cailley, D., Rooryck, C., Paubel, A., Metay, C., Dusser, A., Pasquier, L., Béri, M., Bonnet, C., Jaillard, S., Dubourg, C., Tou, B., Quéré, M.-P., Soussi-Zander, C., Toutain, A., Lacombe, D., Arveiler, B., de Vries, B. B.A., Jonveaux, P., David, A. and Le Caignec, C. (2012), Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures. Am. J. Med. Genet., 158A: 1633–1640. doi: 10.1002/ajmg.a.35423
How to Cite this Article: Thierry G, Bénéteau C, Pichon O, Flori E, Isidor B, Popelard F, Delrue M-A, Duboscq-Bidot L, Thuresson A-C, van Bon BWM, Cailley D, Rooryck C, Paubel A, Metay C, Dusser A, Pasquier L, Béri M, Bonnet C, Jaillard S, Dubourg C, Tou B, Quéré M-P, Soussi-Zander C, Toutain A, Lacombe D, Arveiler B, de Vries BBA, Jonveaux P, David A, Le Caignec C. 2012. Molecular characterization of 1q44 microdeletion in eleven patients reveals three candidate genes for intellectual disability and seizures. Am J Med Genet Part A. 158A:1633–1640.
Gaelle Thierry and Claire Bénéteau contributed equally to this work.
- Issue published online: 18 JUN 2012
- Article first published online: 7 JUN 2012
- Manuscript Accepted: 26 MAR 2012
- Manuscript Received: 21 DEC 2011
- La Fondation pour la Recherche Médicale
- intellectual disability;
- corpus callosum;
Patients with a submicroscopic deletion at 1q43q44 present with intellectual disability (ID), microcephaly, craniofacial anomalies, seizures, limb anomalies, and corpus callosum abnormalities. However, the precise relationship between most of deleted genes and the clinical features in these patients still remains unclear. We studied 11 unrelated patients with 1q44 microdeletion. We showed that the deletions occurred de novo in all patients for whom both parents' DNA was available (10/11). All patients presented with moderate to severe ID, seizures and non-specific craniofacial anomalies. By oligoarray-based comparative genomic hybridization (aCGH) covering the 1q44 region at a high resolution, we obtained a critical deleted region containing two coding genes—HNRNPU and FAM36A—and one non-coding gene—NCRNA00201. All three genes were expressed in different normal human tissues, including in human brain, with highest expression levels in the cerebellum. Mutational screening of the HNRNPU and FAM36A genes in 191 patients with unexplained isolated ID did not reveal any deleterious mutations while the NCRNA00201 non-coding gene was not analyzed. Nine of the 11 patients did not present with microcephaly or corpus callosum abnormalities and carried a small deletion containing HNRNPU, FAM36A, and NCRNA00201 but not AKT3 and ZNF238, two centromeric genes. These results suggest that HNRNPU, FAM36A, and NCRNA00201 are not major genes for microcephaly and corpus callosum abnormalities but are good candidates for ID and seizures. © 2012 Wiley Periodicals, Inc.